Intrinsic Value of S&P & Nasdaq Contact Us

Cutera, Inc. CUTR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.25
+40405.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cutera, Inc. (CUTR) .

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+40405.7%).
  • Analyst consensus target $39.25 (+40405.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
15/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — CUTR

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-8.19
Book Value / Share$0.00
Revenue / Share$10.68
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$39.25 (+40405.7%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-0.74 $78.14M $-10.61M -13.6%
2015 $-0.32 $94.76M $-4.44M -4.7%
2016 $0.19 $118.06M $2.58M 2.2%
2017 $2.04 $151.49M $29.99M 19.8%
2018 $-2.23 $162.72M $-30.77M -18.9%
2019 $-0.88 $181.71M $-12.35M -6.8%
2020 $-1.43 $147.68M $-23.88M -16.2%
2021 $0.11 $231.27M $2.06M 0.9%
2022 $-4.39 $252.4M $-82.34M -32.6%
2023 $-8.19 $212.37M $-162.83M -76.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message